Giorgia Battipaglia

24PUBLICATIONS
150CO-AUTHORS
Epidemiological modellingMolecular medicineCardiovascular medicine and haematology not elsewhere classifiedHaematologyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 05, 2026
Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo).

|May 26, 2026
The 2026 definition of ruxolitinib refractoriness in severe acute GVHD.

|Apr 01, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Christopher Armstrong, Kavita Raj, Giorgia Battipaglia

|Dec 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.

Alexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster

|Dec 04, 2025
Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.

Calogero Vetro, Bruno Garibaldi, Francesco Grimaldi

|Nov 26, 2025
Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines Committee.

Giorgia Battipaglia, Claudia Wehr, Rick Admiraal

Pageof 4

Frequent Collaborators

9 joint publications

Annalisa Ruggeri

8 joint publications

Patrizia Chiusolo

7 joint publications

Nicola Polverelli

6 joint publications

Juan Carlos Hernández-Boluda